glp-1 online program PlushCare Launches Enhanced Weight Loss to Expand National Access to Prescriptions Through Not all weight loss solutions

In published Phase 3 trials, mean weight loss for retatrutide at 80 weeks (28.3%) exceeded the mean for tirzepatide in SURMOUNT-1 at 72 weeks (22.5%)

GLP-1 receptor agonists are not licensed for PCOS in the UK

Marre, M., Shaw, J., Brndle, M., Bebakar, W

Many of our patients are utilizing medications to support their journey, and were excited to announce a partnership that makes this easier and more affordable

Additionally, The Treat & Reduce Obesity Act of 2023 would allow Medicare to cover anti-obesity medication (AOM) coverage, but is unlikely to survive due to the high cost of medication and the lack of ROI for that spend

GLP-1 also suppresses glucagon, a hormone produced by the pancreas that normally raises blood sugar